Immediate Impact
57 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
A comprehensive review of monkeypox virus and mpox characteristics
2024 Standout
Works of Thomas P.H. Meyer being referenced
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
2019
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas P.H. Meyer | 168 | 193 | 42 | 165 | 7 | 296 | |
| Günter Silbernagl | 155 | 184 | 39 | 190 | 8 | 289 | |
| Alvin L. Smith | 101 | 144 | 87 | 110 | 12 | 284 | |
| S. Lay | 66 | 202 | 105 | 92 | 6 | 323 | |
| Caitlin L. Rowe | 64 | 138 | 61 | 96 | 8 | 289 | |
| Benjamin N. Greener | 106 | 130 | 57 | 92 | 8 | 307 | |
| Marloes A. Naarding | 78 | 143 | 104 | 96 | 7 | 327 | |
| Meixi Chen | 138 | 246 | 65 | 92 | 8 | 328 | |
| Chwan Hong Foo | 131 | 61 | 55 | 75 | 8 | 262 | |
| David Alejandro Bejarano | 115 | 133 | 45 | 38 | 10 | 260 | |
| Ann Dauphin | 110 | 223 | 150 | 62 | 7 | 322 |
All Works
Loading papers...